StartupsFinSMEs1 day ago
Lycia Therapeutics Raises $75M in Series D Funding
1 min read
Lycia Therapeutics raised $75 million in Series D funding. The company focuses on developing targeted protein degradation therapies. The financing will support the advancement of its pipeline of clinical-stage programs.
Level
Hype check
Tap to vote and see what everyone thinks.